People · Operator
Named in public records as an officer, director or promoter · active 2007–2012 · Pharmaceuticals, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Auspex Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $82.8M | $951.9M | 2007 |
| Naviscan, Inc | — | Other Health Care | Seed | $5.9M | $24.8M | 2012 |
R. Gary Gilmore at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside R. Gary Gilmore on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael Grey | 1 | 10 |
| David Collier | 1 | 8 |
| Alan Fuhrman | 1 | 5 |
| Pratik Shah | 1 | 5 |
| MICHAEL J. WARD | 1 | 5 |
| Samuel Saks | 1 | 3 |
| Timothy Mills | 1 | 3 |
| Paul J Mirabella | 1 | 3 |
| Abhi Acharya | 1 | 3 |
| Michael Ward | 1 | 3 |
| Alan J. Fuhrman | 1 | 2 |
| Gina Dubbe | 1 | 2 |
| Andreas Gary Sommer | 1 | 1 |
| Rod A. Ferguson | 1 | 1 |
| Andreas Sommer | 1 | 1 |
| Sepehr Sarshar | 1 | 1 |
| David C. Collier | 1 | 1 |
| Pratik A. Shah | 1 | 1 |
| Gaurav A. Aggarwal | 1 | 1 |
| Samuel C. Saks | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.